Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Internal and Emergency Medicine|October 20, 2011
Critical limb ischemiaPaolo Gresele, Chiara Busti, Tiziana FierroEuropean Journal of Ophthalmology|October 21, 2015
Reasons for visits to an emergency center and hemostatic alterations in patients with recurrent spontaneous subconjunctival hemorrhageCarlo Cagini, Alessia Iannone, Anna Bartolini, et al.Platelets|March 24, 2020
Long-term treatment with thalidomide for severe recurrent hemorrhage from intestinal angiodysplasia in Glanzmann ThrombastheniaFrancesco Paciullo, Tiziana Fierro, Filippo Calcinaro, et al.Thrombosis Research|January 20, 2019
Inhibition of platelet function after ocular administration of non-steroidal anti-inflammatory drugsEmanuela Falcinelli, Alessia Iannone, Anna Maria Mezzasoma, et al.Clinical Chemistry and Laboratory Medicine|June 19, 2015
Prevalence of hemostatic alterations in patients with recurrent spontaneous subconjunctival hemorrhageTiziana Fierro, Anna Bartolini, Anna Maria Mezzasoma, et al.Thrombosis Research|September 23, 2014
A novel congenital dysprothrombinemia leading to defective prothrombin maturationValeria Bafunno, Loredana Bury, Giovanni Luca Tiscia, et al.Blood|September 17, 2010
Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutationsAlessandro Pecci, Paolo Gresele, Catherine Klersy, et al.Scientific Reports|June 24, 2024
Low platelet count at admission has an adverse impact on outcome in patients with acute coronary syndromes: from the START Antiplatelet registryPaolo Gresele, Giuseppe Guglielmini, Maurizio Del Pinto, et al.Plos One|May 5, 2012
Alteration of liver enzymes is a feature of the MYH9-related disease syndromeAlessandro Pecci, Ginevra Biino, Tiziana Fierro, et al.Haematologica|July 6, 2019
Eltrombopag for the treatment of inherited thrombocytopenias: a phase II clinical trialCarlo Zaninetti, Paolo Gresele, Antonella Bertomoro, et al.Pageof 2